Status:
UNKNOWN
Efficacy of Pigmented Rice on Reducing Cardiometabolic Risk Factors Among Filipino Adults
Lead Sponsor:
University of Santo Tomas
Conditions:
Dyslipidemias
Overweight or Obesity
Eligibility:
All Genders
20-59 years
Phase:
NA
Brief Summary
The primary purpose of this clinical trial is to investigate whether the consumption of pigmented rice (black rice) in the diet improves cardiovascular health, specifically body weight, lipids, and gl...
Detailed Description
The goal of this clinical trial is to test if pigmented rice consumption can lower the cardiometabolic risk factors of adults. The main question\[s\] it aims to answer are: * Will pigmented rice sign...
Eligibility Criteria
Inclusion
- Aged 20-59 years.
- Body mass index between 18.5 -35 kg/m2
- Elevated cholesterol (total cholesterol \>200 mg/dL or LDL cholesterol 130-190 mg/dL), and/or impaired fasting glucose (100-125mg/dL)
- Eat rice as a staple food at least twice per day
Exclusion
- Are pregnant or lactating
- Regularly consume pigmented rice (two meals per day in the past 4 weeks)
- Have cardiovascular disease (hypertension, stroke, ischemic heart disease, myocardial infarction, or congestive heart failure) or diabetes mellitus
- Take cholesterol or glucose-lowering medications
- Have elevated blood pressure (\>130/80 mmHg)
- Have an illness that may influence lipid metabolism or metabolic rate (liver cirrhosis, pancreatitis, chronic kidney disease, hyperthyroidism, hypothyroidism)
- Take supplements that may influence lipids and glucose levels (including polyphenols)
- Are on a strict diet regimen (calorie-restricted or excluding food groups, examples: (Examples: Ketogenic diet, Intermittent fasting, No Rice diet)
- Have an active lifestyle (Ex. Goes to the gym daily, regularly (≥3 times a week) and perform vigorous activities such as lifting weights, swimming, cycling fast or uphill, or running, or athlete)
Key Trial Info
Start Date :
October 13 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 30 2024
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06092632
Start Date
October 13 2023
End Date
November 30 2024
Last Update
October 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Santo Tomas
Manila, National Capital Region, Philippines, 1015